首页> 美国卫生研究院文献>Cell Death Disease >YAP1 contributes to NSCLC invasion and migration by promoting Slug transcription via the transcription co-factor TEAD
【2h】

YAP1 contributes to NSCLC invasion and migration by promoting Slug transcription via the transcription co-factor TEAD

机译:YAP1通过促进转录辅助因子TEAD的Slug转录来促进NSCLC的侵袭和迁移。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Yes-associated protein 1 (YAP1) contributes to the development of multiple tumors, but the mechanism underlying YAP1 deregulation in non-small cell lung cancer (NSCLC) remains unclear. By performing immunohistochemistry (IHC) assays, we found that YAP1 was significantly upregulated in NSCLC compared with adjacent tissues; therefore, we sought to elucidate whether the upregulation of YAP1 contributes to NSCLC progression. MTT and transwell assays showed that YAP1 overexpression promoted proliferation, migration, and invasion in the NSCLC cell lines A549 and H460; YAP1 overexpression also promoted the significant differential expression of epithelial-mesenchymal transition (EMT)-related markers. Nevertheless, YAP1 knockdown alleviated TGF-β1-induced EMT and proliferation, migration, and invasion in NSCLC. Furthermore, western blotting showed that the co-transcription complex YAP1/TEAD was impaired by YAPS94A (a YAP1 mutant without the TEAD binding site), and verteporfin (a small molecular inhibitor of YAP1) inhibited A549 and H460 cell metastasis and EMT-related markers expression, indicating that TEAD mediated the NSCLC aggressiveness induced by YAP1. Moreover, sequence analysis and ChIP and luciferase assays confirmed that YAP1 transcriptionally activated Slug expression by binding to TEAD. Importantly, silencing YAP1 inhibited A549 cell tumorigenesis and EMT and downregulated Slug expression in vivo. Overall, our findings revealed that YAP1 is a driver of NSCLC metastasis because YAP1 promoted the EMT program by inducing Slug transcription.
机译:是相关蛋白1(YAP1)有助于多种肿瘤的发展,但非小细胞肺癌(NSCLC)中YAP1失控的潜在机制仍不清楚。通过进行免疫组织化学(IHC)分析,我们发现与邻近组织相比,NSCLC中的YAP1明显上调。因此,我们试图阐明YAP1的上调是否有助于NSCLC进展。 MTT和transwell分析表明,YAP1过表达促进了NSCLC细胞系A549和H460的增殖,迁移和侵袭。 YAP1过表达还促进了上皮-间质转化(EMT)相关标记的显着差异表达。然而,YAP1组合物减轻了TGF-β1诱导的EMT以及NSCLC中的增殖,迁移和侵袭。此外,western blotting显示共转录复合物YAP1 / TEAD被YAPS94A(一种没有TEAD结合位点的YAP1突变体)削弱,而verteporfin(一种YAP1的小分子抑制剂)抑制了A549和H460细胞的转移以及与EMT相关的标志物表达,表明TEAD介导了YAP1诱导的NSCLC侵袭性。此外,序列分析以及ChIP和萤光素酶测定法证实YAP1通过结合TEAD转录激活了Slug表达。重要的是,沉默YAP1抑制体内A549细胞的肿瘤发生和EMT,并下调Slug表达。总体而言,我们的发现表明YAP1是NSCLC转移的驱动因素,因为YAP1通过诱导Slug转录促进了EMT程序。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号